Eliem Therapeutics files for IPO as another Seattle-area biotech firm set to go public by Charlotte Schubert on July 19, 2021July 19, 2021 at 11:49 am Eliem Therapeutics, a clinical stage biotech company generating therapies for pain, depression and other nervous-system related conditions, has filed to go public via an IPO. The company’s filing with the… Read More